We are live on ! Find out more
VIE

Viela Bio, Inc. Common Stock
VIE

Delisted

VIE was delisted on the 12th of March, 2021.

Back to rankings

65 hedge funds and large institutions have $1.09B invested in Viela Bio, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 30 increasing their positions, 8 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 6

275% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 8

48% more capital invested

Capital invested by funds: $732M → $1.09B (+$354M)

38% more funds holding

Funds holding: 47 → 65 (+18)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
65
Holders Change
+18
Holders Change %
+38.3%
% of All Funds
1.33%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
24
Increased
30
Reduced
8
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$148M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$82.4M
3
BlackRock
BlackRock
New York
+$41M
4
State Street
State Street
Massachusetts
+$24.4M
5
Goldman Sachs
Goldman Sachs
New York
+$10.8M

Top Sellers

Rank Fund Capital Flow
1
HA
HHLR Advisors
Cayman Islands
-$80.4M
2
CAM
Cormorant Asset Management
Massachusetts
-$11.3M
3
Viking Global Investors
Viking Global Investors
Connecticut
-$9.1M
4
ECM
ExodusPoint Capital Management
New York
-$1.07M
5
Ameriprise
Ameriprise
Minnesota
-$363K
Name Holding Trade Value Shares
Change 		Change in
Stake
VOYA Investment Management
51
VOYA Investment Management
Georgia
$298K +$312K +6,890 New
MLICM
52
Metropolitan Life Insurance Company (MetLife)
New York
$271K +$192K +4,243 +211%
Prudential Financial
53
Prudential Financial
New Jersey
$269K +$281K +6,206 New
AAMU
54
Amundi Asset Management US
Massachusetts
$221K -$4.53K -100 -2%
Rafferty Asset Management
55
Rafferty Asset Management
New York
$218K +$227K +5,022 New
SO
56
STRS Ohio
Ohio
$203K +$149K +3,300 +236%
TRCT
57
Tower Research Capital (TRC)
New York
$182K +$190K +4,195 New
DCM
58
Dupont Capital Management
Delaware
$110K +$115K +2,550 New
AIP
59
Ameritas Investment Partners
Nebraska
$77K +$58.8K +1,298 +277%
Bank of Montreal
60
Bank of Montreal
Ontario, Canada
$68K +$72.2K +1,595 New
CSS
61
Cubist Systematic Strategies
Connecticut
$53K +$55.3K +1,222 New
Osaic Holdings
62
Osaic Holdings
Arizona
$2K +$2.26K +50 New
ECM
63
ExodusPoint Capital Management
New York
– -$1.07M -28,193 Closed
Qube Research & Technologies (QRT)
64
Qube Research & Technologies (QRT)
United Kingdom
– -$280K -7,378 Closed
Victory Capital Management
65
Victory Capital Management
Texas
– -$188K -4,944 Closed
UBS Group
66
UBS Group
Switzerland
– -$124K -3,273 Closed
TCM
67
Tekla Capital Management
Massachusetts
– -$19K -500 Closed
PCIA
68
Prime Capital Investment Advisors
Kansas
– -$8K -200 Closed
Royal Bank of Canada
69
Royal Bank of Canada
Ontario, Canada
– -$7.97K -176 -98%
HIA
70
Harbor Investment Advisory
Maryland
– +$317 +7 New
PHK
71
Point72 Hong Kong
Hong Kong
– +$408 +9 New
1 2
3

VIE Hedge Fund Activity: Q2 2020 in Review

65 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Viela Bio, Inc. Common Stock (VIE) for Q2 2020, worth a combined $1.09B — up 48% from $732M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new VIE positions and 6 closed out — a net gain of 18 holders — while 30 added to existing stakes and 8 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $148M. The largest seller was HHLR Advisors, cutting an estimated $80.4M.

  • 65 institutional investors held Viela Bio, Inc. Common Stock (VIE) as of Q2 2020, up from 47 in Q1 2020.
  • Funds reported $1.09B of Viela Bio, Inc. Common Stock stock for Q2 2020, up 48% quarter-over-quarter.
  • 24 funds opened new Viela Bio, Inc. Common Stock positions in Q2 2020 and 6 closed out, a net change of +18 holders.
  • The largest Viela Bio, Inc. Common Stock buyer in Q2 2020 was Fidelity Investments, an estimated $148M added.
  • The largest Viela Bio, Inc. Common Stock seller in Q2 2020 was HHLR Advisors, an estimated $80.4M sold.

Based on aggregated 13F filings for Q2 2020.